Browse
Submit Data
Databases
API
Help

Dataset Information

30 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

4-Bromo-2-(5-bromo-thio-phen-2-yl)-1-[(5-bromo-thio-phen-2-yl)meth-yl]-5,6-dimethyl-1H-benzimidazole.

ABSTRACT: The title compound, C18H13Br3N2S2, was obtained via the reaction of N-bromo-succinamide with 5,6-dimethyl-2-(thio-phen-2-yl)-1-[(thio-phen-2-yl)meth-yl]-1H-benzimidazole. The compound exhibits rotational disorder of the 5-bromo-thio-phen-2-yl substituent with a refined major:minor occupancy ratio of 0.876?(7):0.124?(7). The 5-bromo-thio-phen-2-yl mean plane is canted to the benzimidazole plane by 20.0?(4) and 21?(4)° in the major and minor components, respectively. In the crystal, weak C-H?N inter-actions link the mol-ecules into infinite C(7) chains along the 21 axes.

SUBMITTER: Geiger HC

PROVIDER: S-EPMC3998606 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

4-Bromo-2-(5-bromo-thio-phen-2-yl)-1-[(5-bromo-thio-phen-2-yl)meth-yl]-5,6-dimethyl-1H-benzimidazole.

Geiger H Cristina HC Donohoe James S JS Geiger David K DK

Acta crystallographica. Section E, Structure reports online 20140326 Pt 4

The title compound, C18H13Br3N2S2, was obtained via the reaction of N-bromo-succinamide with 5,6-dimethyl-2-(thio-phen-2-yl)-1-[(thio-phen-2-yl)meth-yl]-1H-benzimidazole. The compound exhibits rotational disorder of the 5-bromo-thio-phen-2-yl substituent with a refined major:minor occupancy ratio of 0.876 (7):0.124 (7). The 5-bromo-thio-phen-2-yl mean plane is canted to the benzimidazole plane by 20.0 (4) and 21 (4)° in the major and minor components, respectively. In the crystal, weak C-H⋯N int ...[more]

PMID: 24826179

Similar Datasets

5,6-Dimethyl-2-(5-methyl-thio-phen-2-yl)-1-[(5-methyl-thio-phen-2-yl)meth-yl]-1H-benzimidazole.

Project description:The title mol-ecule, C20H20N2S2, is T-shaped and consists of a nearly flat 5,6-dimethyl-2-(5-methyl-thio-phen-2-yl)benzimidazole system approximately perpendicular to the 5-methyl-thio-phen-2-ylmethyl substituent. The 5,6-dimethyl-2-(5-meth-yl-thio-phen-2-yl)benzimidazole system is rotationally disordered about the two imidazole N atoms as approximated by a twofold rotation axis with a refined major/minor occupancy ratio of 0.884?(2):0.116?(2). The benzimidazole ring system is essentially planar, the largest deviations being 0.026?(2) and 0.044?(18)?Å in the major and minor components, respectively. The inter-planar angles between the benzimidazole unit and the 5-methyl-thio-phen-2-yl substituent are 10.8?(3) and 8(3)° in the major and minor components, respectively, and the corresponding angles with the 5-methyl-thio-phen-2-ylmethyl substituent are 88.12?(8) and 89.5?(4)°. In the crystal, mol-ecules are oriented with their 2-(5-methyl-thio-phen-2-yl)benzimidazole mean planes approximately parallel to (11[Formula: see text]) and appear to be held together by ?-? [2-thiophene?imidazole centroid-centroid distance = 4.1383?(7)?Å] and C-H?? contacts. A weak C-H?N hydrogen bond generates infinite chains parallel to [100].

| S-EPMC3998620 | biostudies-literature

5-Bromo-2-(thio-phen-2-yl)-1-(thio-phen-2-ylmeth-yl)-1H-benzimidazole.

Project description:There are two independent mol-ecules in the asymmetric unit of the title compound, C(16)H(11)BrN(2)S(2). In the crystal, weak C-H?N hydrogen bonds and C-H?thio-phene ring inter-actions link the mol-ecules into chains along [100]. The structure exhibits disorder of the 2-thio-phen-2-yl substituent of one of the symmetry-unique mol-ecules with a major:minor component ratio of 0.914?(3):0.086?(3).

| S-EPMC3515228 | biostudies-literature

6-Chloro-2-(thio-phen-2-yl)-1-[(thio-phen-2-yl)meth-yl]-1H-benzimidazole.

Project description:The title compound, C16H11ClN2S2, co-crystallizes with a small amount of the 5-chloro- isomer. The ratio of 6-chloro- to 5-chloro- isomers is 0.969?(2):0.031?(2). One thio-phen-2-yl substitutent displays rotational disorder with 80.6?(4)% of the mol-ecules exhibiting the major orientation. In the crystal, weak C-H?N and C-H?S hydrogen-bonding inter-actions result in chains of mol-ecules parallel to [001].

| S-EPMC3648326 | biostudies-literature

5,6-Dimethyl-2-(pyridin-2-yl)-1-[(pyri-din-2-yl)meth-yl]-1H-benzimidazole.

Project description:The title compound, C20H18N4, was obtained via the condensation of 4,5-di-methyl-benzene-1,2-di-amine with pyridine-2-carbaldehyde. The plane of the 2-(pyridin-2-yl) substitutent is canted by 2.75?(11)° from the plane of the benzimidazole system. The mol-ecule exhibits an S(6) C-H?N intra-molecular hydrogen-bond motif. In the crystal, C-H?N hydrogen bonds link pairs of mol-ecules related by a crystallographic inversion center, forming R 2 (2)(20) rings. Additional weak C-H?N hydrogen bonds result in C(9) chains parallel to [001].

| S-EPMC3998417 | biostudies-literature

2-(Thio-phen-2-yl)-1-(thio-phen-2-ylmeth-yl)-1H-benzimidazole.

Project description:In the title compound, C(16)H(12)N(2)S(2), the thio-phene groups are rotationally disordered over two sets of sites, by approximately 180°, with occupancy ratios of 0.916?(2):0.084?(2) and 0.903?(2):0.097?(2). The major components of the thio-phene and methyl-ene substituted thio-phene rings are canted by 24.06?(12) and 85.07?(10)°, respectively, from the benzimidazole ring system plane and the dihedral angle between the major component thio-phene ring planes is 84.90?(14)°. In the crystal, there is a weak C-H?N hydrogen bond which links mol-ecules into chains.

| S-EPMC3275178 | biostudies-literature

5,6-Dimethyl-4-(thio-phen-2-yl)-1H-pyrazolo-[3,4-b]pyridin-3-amine.

Project description:In the title mol-ecule, C(12)H(12)N(4)S, the thio-phene ring is disordered over two orientations with a refined site-occupancy ratio of 0.777?(4):0.223?(4). The pyrazolo-pyridine ring system is essentially planar with an r.m.s. deviation of 0.0069?(3)?Å and makes dihedral angles of 82.8?(2) and 72.6?(5)°, respectively, with the major and minor components of the thio-phene ring. In the crystal, mol-ecules are linked into a chain along the a axis by a pair of N-H?N(pyrazole) hydrogen bonds and a pair of N-H?N(pyridine) hydrogen bonds, both having a centrosymmetric R(2) (2)(8) graph-set motif. A C-H?? inter-action is also present.

| S-EPMC3295413 | biostudies-literature

1-(4-Bromo-benz-yl)-2-(4-bromo-phen-yl)-1H-benzimidazole.

Project description:There are two mol-ecules in the asymmetric unit of the title compound, C20H14Br2N2. In the first, the dihedral angles between the mean plane of the benzimidazole group and those of the 4-bromo-benzyl and 4-chloro-phenyl groups are 50.72?(17) and 71.29?(16)°, respectively, while the corresponding angles in the second mol-ecule are 42.09?(16) and 89.05?(17)°. The 4-bromo-benzyl and 4-bromo-phenyl groups make an angle of 68.1?(2) and 85.1?(21)° with each other in the two mol-ecules. In the crystal, weak C-H?N and C-H?Br hydrogen bonds link the mol-ecules along the c-axis direction. Br?Br inter-actions [3.5733?(9)Å] are also observed.

| S-EPMC4011315 | biostudies-literature

2-[4-(Tri-fluoro-meth-yl)phen-yl]-1H-benzimidazole.

Project description:In the title compound, C14H9F3N2, the mean planes of the benzimidazole ring system and the tri-fluoro-methyl-substituted benzene ring form a dihedral angle of 30.1?(1)°. In the crystal, mol-ecules are linked by N-H?N hydrogen bonds into chains along [010]. Weak C-H?F hydrogen bonds and a weak C-H?? inter-action connect the chains into a two-dimensional network parallel to (001).

| S-EPMC4120605 | biostudies-literature

2-[4-(Trifluoro-meth-oxy)phen-yl]-1H-benzimidazole.

Project description:In the title compound, C(14)H(9)F(3)N(2)O, the best planes of the benzimidazole group and benzene ring form a dihedral angle of 26.68?(3)°. In the crystal, N-H?N hydrogen bonds link the mol-ecules into infinite chains parallel to the c axis. Stacking inter-actions between the benzimidazole groups [centroid-centroid distance = 3.594?(5)?Å] assemble the mol-ecules into layers parallel to (100). The trifluoro-methyl group is disordered over three sets of sites with site-occupancy factors of 0.787?(4), 0.107?(7) and 0.106?(7).

| S-EPMC3569794 | biostudies-literature

1-Phenyl-2-[4-(trifluoro-meth-yl)phen-yl]-1H-benzimidazole.

Project description:In the title mol-ecule, C(20)H(13)F(3)N(2), the benzimidazole unit is close to being planar [maximum deviation = 0.012?(1)?Å] and forms dihedral angles of 31.43?(7) and 61.45?(9)° with the 4-(trifluoromethyl)phenyl and 1-phenyl rings, respectively; the dihedral angle between these rings is 60.94?(10)°. In the crystal, C-H?F hydrogen bonds link the mol-ecules into chains along the c-axis direction. The CF(3) group is rotationally disordered with an occupancy ratio of 0.557?(8):0.443?(8) for the F atoms.

| S-EPMC3569777 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data